ubiquitous expression in mammalian tissues, it is difficult to determine the specificity of each of the ras gene products regarding tissue, function, or activation by specific guanine nucleotide exchange factors. K-ras-deficient embryos die in uterus between 12 and 14 days of gestation due to liver defects and anemia (33, 40) ; H-ras, N-ras, H-ras plus N-ras, and K-ras4A knockout (KO) mice are viable and do not show any obvious abnormalities (20, 33, 56, 75) , indicating that only K-ras4B is essential for mouse embryogenesis and development to the adult stage. Many tumors are associated with mutations in a specific Ras family member (8, 63) . This is additional evidence for the unique roles of H-, K-, and N-Ras. There are different expression levels for each ras gene depending on the tissue and/or developmental stage (42, 72) ; moreover, different Ras isoforms follow different intracellular processing pathways and their final mature products locate to different membrane microdomains or subcellular compartments, supporting the notion of distinct cellular roles for the different Ras isoforms (19, 25, 26, 44, 46, 55, 60, 65, 77) .
Ras activates several intracellular signaling pathways (63) . ERK/mitogen-activated protein kinase (MAPK) and protein kinase B/Akt are the most well-known routes. The ERK/ MAPK pathway regulates cell growth, differentiation, and apoptosis, while Akt induces protein synthesis and promotes cell survival by protecting cells from apoptosis. There is a close relationship between transforming growth factor-␤ (TGF-␤) and Ras signaling pathways: Ras alters the expression of TGF-␤1 type II receptor counteracting TGF-␤ signaling (3) . On the other hand, TGF-␤1 overcomes Ras mitogenic effects (28, 41, 53) . Our laboratory has shown that the lack of both Hand N-Ras isoforms in fibroblasts downregulates extracellular matrix (ECM) synthesis and mediates proliferation through MEK/ERK activation. TGF-␤1 can upregulate ECM synthesis via phosphatidylinositol-3-kinase (PI3K)/Akt signaling and simultaneously inhibits the ERK pathway (45) . However, the effect of H-Ras isoform deficiency has not yet been assessed. We recently reported that H-Ras regulates myofibroblast proliferation in a model of obstructive nephropathy in mice (22) .
In the present work, we study the effect of H-ras deficiency in basal and TGF-␤1-mediated ECM synthesis and the proliferation and migration in cultured embryonic fibroblasts isolated from mice lacking the H-Ras isoform (H-ras Ϫ/Ϫ ). The Ras signaling pathways MAPK/ERK and PI3K/Akt have also been studied.
MATERIALS AND METHODS

Materials and Reagents
Crystal violet was from Fluka (Buchs, Switzerland). Normal goat serum, rabbit anti-mouse Akt 1/2 and rabbit anti-rat ERK 1, and mouse anti-human phospho-ERK antibodies were from Santa Cruz Biotechnology (Madrid, Spain). Rabbit anti-human phospho-Akt antibody was from Cell Signaling Technology (Barcelona, Spain). Rabbit anti-mouse collagen type I and fibronectin antibodies were from Chemicon International (Temecula, CA). Mouse anti-human Ras antibody, Raf-1 Ras binding domain agarose conjugate, and magnesium lysis buffer (MLB) were from Upstate Biotechnology (Barcelona, Spain). Mouse anti-human PCNA antibody was from Transduction Laboratories (Madrid, Spain). Rabbit anti-human Ki67 was obtained from MD (Granada, Spain). Goat anti-rabbit Cy3 was from Jackson Immunoresearch (West Grove, PA). Goat anti-rabbit and anti-mouse IgG (HϩL) horseradish peroxidase-conjugated antibodies, nitrocellulose membrane, and Dc protein assay were from Bio-Rad (Madrid, Spain). Hoechst 33258 was from Molecular Probes (Barcelona, Spain). ECL chemiluminescence Western blotting system and Hyperfilm X-ray film were from Amersham Biosciences (Barcelona, Spain). Tri-reagent was from Molecular Research Center (Madrid, Spain). TGF-␤1 was from R&D Systems (Minneapolis, MN). U0126 was from Calbiochem (Madrid, Spain). JetPEI transfection reagent was from Polyplus Transfection (Illkirch, France). [ 3 H]proline was from American Radiolabeled Chemicals (St. Louis, MO). Fetal calf serum (FCS), Dulbecco's modified Eagle's medium (DMEM), and trypsin solution were from Bio Whittaker Labs (Barcelona, Spain). The sterile plastic material used in cell culture was from Nunc (Roskilde, Denmark). Cell culture inserts were from Falcon (Madrid, Spain). Flow cytometer FACS Calibur and computer software Cell QUEST and Paint-A-gate were from Becton Dickinson Biosciences (San Jose, CA), Wallac 1409 DSA liquid scintillation counter was from Perkin Elmer (Waltham, MA), and Scion Image software was from Scion (Frederick, MD). All other reagents were of analytical grade and obtained from Sigma Química (Madrid, Spain), and Merck (Madrid, Spain).
Cell Culture and Growth Factor Stimulation
H-ras
ϩ/ϩ and H-ras Ϫ/Ϫ fibroblasts were subcultured as previously reported (20) . Briefly, embryos from H-ras Ϫ/Ϫ and wild-type (WT) mice were recovered at day 15 postcoitum, mechanically minced, and treated with trypsin for 30 min before plating. Immortalized cultures that survived crisis after 15-20 passages were identified and cloned and their genotypes reconfirmed by PCR analysis, as later described. Expression of Ras protein isoforms was monitored by immunoblotting with specific antibodies directed against H-Ras. Cells were seeded in 100-mm petri dishes (Western blot and cell cycle analysis), and at 20,000 or 9,000 cells/well in 24-well plates (total collagen measurements and proliferation studies, respectively). Cells were grown in DMEM medium containing 10% FCS and 100 U/ml penicillinstreptomycin at 37°C, 5% CO 2. When cultures achieved 80 -90% confluence, cells were serum starved for 24 h and treated with active human recombinant TGF-␤1 (1 ng/ml) or control vehicle during 24 h in the absence of serum. Inhibitors used included the mitogenactivated kinase/ERK kinase-1 (MEK-1) inhibitor U0126 (20 M) and the PI3K inhibitor LY294002 (20 M); pretreatment with these substances lasted 30 min.
Crystal Violet Staining
Total cell number was measured using a colorimetric method previously described (48) . Subconfluent cells in 24-well plates were incubated for 24 h, fixed for 10 min with 10% glutaraldehyde, and washed with phosphate-buffered saline solution (PBS). Nuclei were stained by incubating the cells 30 min in 1% crystal violet solution.
Wells were washed again with PBS and left overnight to dry, and 2 ml of 10% acetic acid were added in each well. Optical density at 595 nm was proportional to the number of viable cells in each well.
Immunofluorescence Analysis of Ki67 Expression
The percentage of cells stained for Ki67 indicates the growth fraction (10) . Cells on coverslips were fixed with 4% paraformaldehyde, washed with calcium-magnesium PBS (PBS Ca-Mg: 1 mM CaCl 2, 1 mM MgSO4, 0.81% NaCl, 2.6 mM H2KPO4, 4.1 mM HNa2PO4), permeabilized with 0.1% Triton X-100, 0.2% BSA, and 0.5% sodium azide, quenched with 50 mM NH4Cl in PBS Ca-Mg, blocked 30 min with 10% normal goat serum (NGS) in PBS Ca-Mg, incubated for 2 h with rabbit anti-human Ki67 (dilution 1/50) in PBS Ca-Mg with 2% NGS, and incubated for 30 min with goat anti-rabbit Cy3 (Jackson Immunoresearch) (1/1,000) in PBS Ca-Mg with 2% NGS in a dark chamber. Nuclei staining was performed by 5 min incubation with 2 M Hoechst 33258 in the dark. Confocal images were obtained using a Zeiss Axiovert 200M microscope with a HeNe laser with 543-nm excitation for rhodamine and Hg laser with 365-nm excitation for DAPI. All captured images had identical parameters for intensity, pinhole aperture, etc.
Affinity Precipitation of Ras-GTP in Cell Lysates (Ras Pull-Down)
Ten micrograms of Raf-1 Ras binding domain agarose conjugate were incubated with 1 mg of protein obtained by cell lysis in MLB (25 mM HEPES, pH 7.5, 150 mM NaCl, 1% Igepal CA-630, 10 mM MgCl 2, 0.25% sodium deoxycolate, 1 mM EDTA) containing 10% glycerol and proteases and phosphatases inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 g/ml aprotinin, 1 mM Na 3VO4 and 25 mM NaF) and rocked 30 min at 4°C. Agarose conjugates were recovered by 5 s centrifugation at 14,000 g, 4°, washed three times with 500 l of lysis buffer, resuspended in 10 ml of Laemmli sample buffer (10% 2-mercaptoethanol, 4% SDS, 0.05% bromophenol blue, 20% glycerol, 125 mM Tris, pH 7.5) and boiled for 5 min. Sample supernatants were used for detection of Ras-GTP by Western blot analysis.
Cell Transfection
Phospho-ERK overexpression was induced by transfection of a plasmid (pCDNA MEK E) encoding a constitutively active MEK (2) . Fibroblasts were transfected during 7 h using jetPEI transfection reagent according to the manufacturer's instructions. Then, cells were incubated during 24 h in 10% FCS DMEM. Next, cells were grown in 0.5% FCS DMEM medium for 24 h and crystal violet staining was performed, or cells were lysed for Western blot analysis.
Western Blot Analysis
Western blot analysis was performed as previously described (45) . Membranes were incubated with the following antibodies: anti-Akt 1/2 (dilution: 1/1,000), anti-ERK 1 (1/10,000), anti-phospho-ERK (1/2,000), anti-phospho-Akt (1/1,000), anti collagen type I (1/20,000), anti-fibronectin (1/30,000), anti-PCNA (1/5,000), and anti-Ras (1/ 1,000). Actin and tubulin are affected by TGF-␤1 treatment and therefore were not used as loading controls. Instead we utilized total ERK 1/2 levels as controls for protein loading because their basal levels showed no differences between H-ras ϩ/ϩ and H-ras Ϫ/Ϫ fibroblasts after TGF-␤1 treatment, as we had previously found in H-and N-Ras double-KO fibroblasts (45) . Previous results from our laboratory showed that total ERK 1/2 did not change in renal tissue of mice undergoing different manipulations leading to fibrosis and proliferation (61) while tubulin and actin did change.
CCT CCT GAT AGT-3=, and 182-202 bp, 5=-GCC CAG TGA TTT CAG CAA AGG-3=. For human collagen type I (␣1), 5,292-3,314 bp, 5=-TGT TGC TGA AAG ACT ACC TCG T-3=, and 5,572-5,594 bp, 5=-CCT CCC ATG TTA AAT AGC ACC T-3=. For GAPDH, 5=-TGA AGG TCG GTG TGA ACG GAT TTG GC-3= and 5=-CAT GTA GGC CAT GAG GTC CAC CAC-3=. Cycling conditions for collagen I were as follows: 95°C, 5 min, 40 cycles of 1 min 95°C, 1 min 52°C and 1 min 72°C, and an elongation cycle of 5 min 72°C; for fibronectin: 5 min 95°C, 35 cycles of 1 min 95°C, 1 min 61.6°C, and 1 min 72°C, and an elongation cycle of 5 min 72°C; for GAPDH: 5 min 94°C, 28 cycles of 1 min 94°C, 1 min 60°C, and 1.5 min 72°C, and an elongation cycle of 5 min 72°C, using a Bio-Rad Thermal Cycler. Amplified products were analyzed by electrophoresis in 1.5% agarose gels.
Total Collagen Synthesis Measurement
Collagen content in the culture medium was quantified by measuring the incorporation of [ 3 H]proline into collagen proteins, as described elsewhere (13) . Radiolabeling was carried out by incubation for 24 h in fresh DMEM serum-free medium containing 0.15 mM ␤-aminopropionitrile, 210 mM ascorbic acid, 183 mM proline, and 1 Ci/well [ 3 H]proline (specific activity: 40 Ci/mmol). Proteins were precipitated in ice-cold 10% trichloroacetic acid, and the pellet was washed and resuspended in 0.1 N NaOH. [ 3 H]proline incorporated to collagen proteins was measured in a ␤-scintillation counter.
Cell Cycle Determination by Flow Cytometry
Cells were resuspended in PBS (10 6 cells/ml) and incubated 10 min with 1.8 ml solution A (60 mg/l trypsin in 0.5 mM Tris-hydroxymethylaminemethane, 3.4 mM trisodium citrate, 0.1% NP40, 1.5 mM spermine, pH 7.6) to break cell membranes and to digest the protein content of the cells. Cell extracts were incubated 10 min with 1.5 ml of solution B (1 g/l RNAse and 0.2 g/l trypsin inhibitor in 0.5 mM Tris-hydroxymethylaminemethane, 3.4 mM trisodium citrate, 0.1% Nonidet P40, 1.5 mM spermine, pH 7.6). After this incubation, 1.5 ml of solution C were added (0.416 g/l propidium iodide in 0.5 mM Tris-hydroxymethylaminemethane, 3.4 mM trisodium citrate, 0.1% Nonidet P40, 1.5 mM spermine, pH 7.6). Finally, cells were introduced into a flow cytometer; data acquisition and analysis were performed using the computer software Cell QUEST and Paint-Agate, respectively.
Wound-Healing Assay
In vitro scratched wounds were created with a straight incision on serum-starved confluent cell monolayers with a sterile disposable pipette tip. Cell migration into denuded areas was monitored over a time course using digital microscopy, and the rate of cell movement was calculated as the time required for half of the wound to be occupied by the cells.
Cell Migration Assay
Fibroblast migration was evaluated in a migration chamber, based on the Boyden assay; each chamber contains an 8-m pore size polycarbonate membrane (which supports optimal migration for fibroblasts). Cell suspension in 2% FCS medium was loaded into the chamber, and invading cells migrated through and attached to the membrane (bottom chamber containing 10% FCS medium), while noninvading cells remained above. Finally, inserts were washed with PBS and fixed with 10% glutaraldehyde, and the number of the cells that had migrated was determined by the crystal violet method.
Statistical Methods
Data are expressed as means Ϯ SE. The Kolmogorov-Smirnov test was used to assess the normality of the data distribution. Comparison of means was performed by one-way analysis of variance (ANOVA).
Statistical differences between groups were assessed by Scheffé's test and Student's t-test. P Ͻ 0.05 was considered statistically significant.
RESULTS
Synthesis and Expression of ECM Proteins
To assess possible differences in both synthesis and expression of constitutive extracellular matrix proteins in the absence of H-Ras isoform, we analyzed the basal and TGF-␤1-induced expression of two characteristic ECM proteins, fibronectin and collagen type I, by RT-PCR and Western blotting in both H-ras Ϫ/Ϫ and WT fibroblasts; we also evaluated the synthesis of total collagen proteins by measuring [ 3 H]proline incorporation into collagen proteins (Fig. 1) . TGF-␤1 treatment (at a concentration of 1 ng/ml for 24 h) was carried out on the basis of previous dose-response and time-course studies in mouse embryonic fibroblasts (44) .
Fibronectin and collagen I expressions, as well as total collagen synthesis, were higher in H-ras Ϫ/Ϫ fibroblasts than in WT fibroblasts in basal conditions. The values observed in basal H-ras Ϫ/Ϫ fibroblasts were similar to those in TGF-␤1-stimulated WT fibroblasts. The increase in collagen synthesis induced by TGF-␤1 was significantly higher in H-ras Ϫ/Ϫ fibroblasts than in WT fibroblasts (Fig. 1E) . TGF-␤1 treatment increased fibronectin expression in WT but not in H-ras Ϫ/Ϫ fibroblasts (Fig. 1B) .
Expression of Ras-GTP and Total Ras
To assess whether the absence of H-Ras isoform caused any difference in the activation of Ras, we studied Ras activation by Western blot analysis after precipitating cellular extracts by Ras pull-down. Ras activation (the ratio of Ras bound to Raf-RBD/total Ras) was similar in H-ras Ϫ/Ϫ and WT fibroblasts. Treatment with 1 ng/ml TGF-␤1 for 24 h did not increase Ras activation in H-ras Ϫ/Ϫ fibroblasts. There were no differences on total Ras expression between H-ras Ϫ/Ϫ and WT fibroblasts (Fig. 2) , possibly because the absence of H-Ras isoform was compensated by a higher expression of the isoforms K-and N-Ras, which were present.
Expression of Ras Effectors, ERK and Akt, and Effect of Their Activation on the Expression of ECM Proteins
MAPK pathway: ERK 1/2 activation. We then determined whether there were any changes in the activation of the MAPK pathway in the absence of H-Ras isoform in fibroblasts. The expression levels of phospho-ERK, the activated form of ERK 1/2, and total ERK 1/2 were analyzed by Western blotting (Fig. 3A) . The expression levels were similar in H-ras Ϫ/Ϫ and WT fibroblasts under basal conditions (Fig. 3A) . TGF-␤1 treatment strongly increased phospho-ERK expression in WT fibroblasts, but this TGF-␤1-induced ERK hyperactivation did not occur in cells lacking H-Ras (Fig. 3A) .
We also analyzed the effect of phospho-ERK 1/2 inhibition by coincubation with the phospho-ERK 1/2 inhibitor U0126 (20 M) for 24 h on both basal and TGF-␤1-induced fibronectin and collagen I expression in H-ras Ϫ/Ϫ and WT fibroblasts. Figure 3B shows the effect of U0126 on phospho-ERK inhibition at different times. ERK inhibition reduced TGF-␤1-induced fibronectin expression only in WT fibroblasts and did not modify TGF-␤1-induced collagen I expression in fibro-blasts with or without H-Ras (Fig. 3, D and E) . It is noteworthy that ERK inhibition reduced basal expression of both fibronectin and collagen I in WT fibroblasts but did not reduce their expression in H-ras Ϫ/Ϫ fibroblasts (Fig. 3, D and E) . On the other hand, phospho-ERK overexpression reduced the higher expression of both fibronectin and collagen type I observed in H-ras Ϫ/Ϫ fibroblasts (Fig. 3C ). PI3K pathway: Akt activation. We also determined whether the absence of the H-Ras isoform could exert any changes on the PI3K signaling pathway. PI3K pathway activation was determined as the ratio between phospho-Akt and total Akt expression by Western blot analysis. The expression of phospho-Akt, the activated form of Akt, was higher in H-ras Ϫ/Ϫ than in WT fibroblasts under basal conditions (Fig. 4A) . TGF-␤1 treatment increased PI3K activation in WT fibroblasts but not in H-ras Ϫ/Ϫ cells (Fig. 4A ). We also analyzed the effect of PI3K inhibition by coincubation with the inhibitor LY294002 (20 M, 24h) on both basal and TGF-␤1-induced fibronectin and collagen I expression in H-ras Ϫ/Ϫ and WT fibroblasts (Fig. 4, C and D) . The effect of LY294002 on phospho-Akt inhibition at different times is shown in Fig. 4B . PI3K inhibition reduced TGF-␤1-induced fibronectin and collagen I expression in WT fibroblasts and TGF-␤1-induced collagen I expression in H-ras Ϫ/Ϫ cells. It is important to note that PI3K inhibition reduced basal expression of fibronectin and collagen I in both WT and H-ras Ϫ/Ϫ fibroblasts (Fig. 4, C and D) .
Cell Cycle
As a preliminary step before studying any changes in fibroblast proliferation in the absence of H-Ras isoform, we have analyzed possible changes in cell cycle by flow cytometry in serum-starved fibroblasts for 24 h. Our results showed a significant reduction in the percentage of H-ras Ϫ/Ϫ cells in phases S, G2, and M of the cell cycle with respect to WT fibroblasts (52.763 Ϯ 0.845% in H-ras Ϫ/Ϫ vs. 70.365 Ϯ 3.470% in WT, P Ͻ 0.01).
Fibroblast Proliferation
Next, we studied whether the absence of H-Ras induced any change on the proliferation of fibroblasts. The effect of TGF-␤1 treatment on cell proliferation was evaluated by immunocytochemistry with Ki67, by nuclei staining with crystal violet and by PCNA Western blot analysis. TGF-␤1 induced a lower increase in Ki67 expression in H-ras Ϫ/Ϫ than in WT fibroblasts (Fig. 5, A and B) . This increase in TGF-␤1-induced Ki67 expression was reduced by either PI3K inhibition or ERK 1/2 inhibition in WT fibroblasts, whereas in H-ras Ϫ/Ϫ fibroblasts it was reduced only in the presence of the PI3K inhibitor (Fig. 6, A and D) .
TGF-␤1-induced proliferation (number of stained nuclei) was significantly lower in H-ras Ϫ/Ϫ than in WT fibroblasts (120.00 Ϯ 3.32% in H-ras Ϫ/Ϫ vs. 146.00 Ϯ 5.08% in WT, P Ͻ 0.01; unstimulated cells: 100%). The increase in fibroblast proliferation induced by TGF-␤1 was reduced by either PI3K inhibition or ERK 1/2 inhibition in both WT and H-ras Ϫ/Ϫ fibroblasts (Fig. 6, B and E) . On the other hand, phospho-ERK overexpression induced an increase in TGF-␤1-induced proliferation in H-ras Ϫ/Ϫ fibroblasts (Fig. 6C) . Moreover, it is important to stress that TGF-␤1-induced PCNA expression was lower in H-ras Ϫ/Ϫ fibroblasts than in control fibroblasts (Fig. 5C ).
Cell Migration
After examining the changes brought about by the absence of H-Ras on ECM synthesis and fibroblast proliferation, we analyzed another of the key processes in the development of fibrosis, cell migration. Fibroblast migration was analyzed by both measuring wound closure time in an in vitro woundhealing assay and determining cell migration by use of a Boyden chamber. Time course studies of wound closure showed that cell movement in H-ras Ϫ/Ϫ fibroblasts was notably slower than in WT cells (Fig. 7, A and B) ; moreover, fibroblast migration in the Boyden chamber was markedly decreased in H-ras Ϫ/Ϫ fibroblasts with respect to WT fibroblasts (Fig. 7C) . Therefore, cell movement is significantly restricted in fibroblasts lacking H-Ras.
ERK inhibition did not modify cell migration in a significant manner in either H-ras Ϫ/Ϫ or WT fibroblasts (Fig. 7, D and E) . Akt inhibition increased wound closure times in WT fibroblasts to values similar to those of H-ras Ϫ/Ϫ fibroblasts (Fig. 7F) ; moreover, Akt inhibition reduced cellular migration in both Hras Ϫ/Ϫ and WT fibroblasts (Fig. 7G) .
DISCUSSION
The family of Ras GTPases function as transducers of extracellular signals regulating cell survival, growth, differentiation, and other functions (12, 17) . The individual role of each Ras isoform for these functions has not yet been completely elucidated. For this research, we studied the effect of the H-Ras isoform on ECM synthesis, and proliferation and migration by immortalized fibroblasts, using cultured embryonic fibroblasts obtained from mice lacking the H-Ras isoform (H-ras Ϫ/Ϫ ), as previously described (20) . Although we have previously shown the effect of the lack of both H-and N-Ras isoforms in fibroblasts (45) , this is the first study showing the individual effect of the absence of the H-Ras isoform in the cellular processes described above.
TGF-␤1 is the main cytokine involved in ECM homeostasis (7, 18, 36) . It also plays a key role in cell proliferation (24, 67) . Ras GTPases participate downstream in the signaling of TGF-␤ (3, 28, 41, 53) . Moreover, TGF-␤ and Ras GTPases share proteins of some cytosolic cascade reactions, such as PI3K/Akt and MEK/ERK 1/2 (4, 12, 17, 62) . Thus, we have assessed the participation of H-Ras on the effects of TGF-␤1 in ECM synthesis, migration, and proliferation. Our laboratory previously reported that renal tubule-interstitial fibrosis induced by unilateral uretheric obstruction (UUO), a process mediated by TGF-␤1 and interstitial fibroblast activation (23) , is associated with Ras, ERK 1/2, and Akt activation (61).
We observed that fibronectin and collagen I expression as well as collagen synthesis were higher in H-ras Ϫ/Ϫ than in WT fibroblasts. Under these conditions, the lack of H-Ras maintains hyperactivation of the PI3K pathway, and PI3K inhibition decreases fibronectin and collagen synthesis in WT and Hras Ϫ/Ϫ fibroblasts. Therefore, the H-Ras isoform may exert a crucial role in the maintenance of ECM homeostasis, preventing excessive ECM synthesis in fibroblasts through the downregulation of PI3K/Akt activity. Although we previously described a lower activation of the ERK 1/2 pathway in Hras Ϫ/Ϫ , N-ras Ϫ/Ϫ double-KO fibroblasts than in wild-type fibroblasts (45) , in the present study the activation of ERK 1/2 was similar in either H-ras Ϫ/Ϫ or wild-type fibroblasts. This suggests that H-Ras is not necessary to activate the MEK/ERK 1/2 route under basal conditions. TGF-␤1 is a cytokine capable of regulating the expression of ECM proteins such as collagen, fibronectin, tenascin, and laminin (6, 9, 76) . As expected, after incubation with TGF-␤1, we observed an augmentation in ECM synthesis in both WT and H-ras Ϫ/Ϫ fibroblasts. However, the TGF-␤1-induced increase in collagen expression and synthesis was higher in H-ras Ϫ/Ϫ fibroblasts than in WT fibroblasts. Moreover, TGF-␤1 raised fibronectin expression in WT but not in H-ras Ϫ/Ϫ fibroblasts, suggesting that H-Ras is necessary for TGF-␤1-dependent fibronectin increase. In WT fibroblasts, TGF-␤1 treatment induced small increases of collagen type I and fibronectin mRNA expression. These increases appear to be responsible for significant increases in the expression of both proteins. The same situation occurs in H-Ras KO fibroblasts under basal conditions. Moreover, in H-Ras KO fibroblasts, TGF-␤1 treatment did not induce an increase in collagen type I mRNA expression, although we observed a significant increase in protein expression. This may be due to posttranscriptional modifications or increased mRNA stability of these proteins under our experimental conditions. We also studied the participation of MEK/ERK and PI3K/ Akt pathways in TGF-␤1-mediated ECM synthesis. ERK has different effects on ECM synthesis depending on the cell type and conditions (15, 27, 43, 49, 51, 71, 72, 73) . ERK 1/2 mediates the inhibition of collagen type I synthesis in skin fibroblasts and in mesangial cells (58) . However, other authors have reported that either an ERK inhibitor or an ERK 1 dominant negative blocks TGF-␤-induced collagen synthesis in hepatic stellate cells (32) and mesangial cells (27) . The participation of PI3K/Akt route in the transduction signaling of several stimuli that promote ECM synthesis and accumulation is also well documented, e.g., in the collagen increase induced by TGF-␤1 in lung fibroblasts (59) , by platelet-derived growth factor in cultured fibroblasts (29) , and by interleukin-18 in cardiac fibroblasts (57). Winbanks et al. (79) reported that the PI3K inhibitor LY294002 induced a 73% reduction in total collagen synthesis in renal fibroblasts. We also reported that TGF-␤1 can upregulate ECM synthesis via PI3K/Akt signaling in fibroblasts (45) , and recently, we reported that administration of LY294002 reduced the UUO-induced increase in fibronectin and collagen I expression in vivo (61).
TGF-␤1 increased the activation of both ERK 1/2 and PI3K pathways only in WT fibroblasts. The fact that ERK hyperactivation induced by TGF-␤1 did not occur in cells lacking H-Ras implies that H-Ras must be necessary for the ERK 1/2 activation induced by TGF-␤1. However, our finding that TGF-␤1 led to incremental activation of PI3K in WT but not in H-ras Ϫ/Ϫ cells may indicate that PI3K was already hyperactivated in H-ras Ϫ/Ϫ resting cells. Inhibition of either the ERK 1/2 pathway or the PI3K pathway resulted in lower TGF-␤1-induced ECM expression in either WT or H-ras Ϫ/Ϫ fibroblasts. Therefore, H-Ras does not seem to be essential for ERK 1/2-mediated or PI3K-mediated ECM synthesis in fibroblasts stimulated by TGF-␤1.
This study is the first to suggest that H-Ras participates in the modulation of processes involved in ECM homeostasis in fibroblasts. H-Ras seems to be essential in the homeostasis of two ECM proteins, fibronectin and collagen I, in unstimulated fibroblasts. In TGF-␤1-stimulated cells, H-Ras is needed for fibronectin regulation whereas it is not necessary for collagen I regulation, although it is important to avoid an excess of collagens. H-Ras appeared dispensable for basal ERK 1/2 activation but fundamental for the TGF-␤1-induced ERK 1/2 hyperactivation. Moreover, H-Ras is essential to maintain the PI3K/Akt pathway downregulation in resting and in TGF-␤1-stimulated fibroblasts. TGF-␤ stimulates proliferation of fibroblasts (14, 34, 78 ). Our results suggest that H-Ras is not strictly required but exerts an upregulating function on the proliferative effect induced by TGF-␤1, as TGF-␤1-induced proliferation was lower in Hras Ϫ/Ϫ than in WT fibroblasts. These findings are consistent with those of Rosseland et al. (64) , who showed that epidermal growth factor (EGF)-induced DNA synthesis was increased in cells expressing constitutive active H-RasV12. in fibroblasts. For example, activation of the MEK/ERK 1/2 cascade regulated fibroblast proliferation induced by insulin growth factor-I (54) and by muscarinic receptor stimulation (47) . Other authors showed the activation of both the MEK/ ERK pathway and the PI3K/Akt pathway in fibroblast proliferation stimulated with ionizing radiation (37) or EGF (31) . Moreover, the PI3K-Akt pathway mediates growth and proliferation induced by Wnt3a protein in NIH3T3 (39) and in renal fibroblasts (79) . However, this is the first study relating TGF-␤-induced proliferation with PI3K or ERK 1/2 and Ras GTPases.
Our results also lead us to propose that H-Ras regulates basal proliferation levels in nonstimulated cells, as we observed a lower number of H-ras Ϫ/Ϫ cells in proliferating phases of the cell cycle and a lower PCNA expression in H-ras Ϫ/Ϫ compared with WT fibroblasts. Rosseland et al. (64) also suggested that H-Ras might be involved in the signaling that leads to cellular proliferation and survival through the ERK and Akt pathways. Recently, we suggested that the reduced renal fibrosis observed in a model of obstructive nephropathy in H-ras Ϫ/Ϫ mice is explained by the reduced fibroblast proliferation (22) .
Many different studies have reported that the activation of the H-ras oncogene increases the migratory activity of fibroblasts, keratinocytes, endothelial cells, melanoma, and mammary epithelial cells, and thereby contributes to the metastatic behavior of tumor cells (1, 11, 21, 30, 38, 50, 68 -70) . Our results confirm that cell migration appeared strongly restricted in fibroblasts lacking H-Ras. This suggests that H-Ras upregulates cell movement and that its presence is essential for normal fibroblast motility. These findings agree with those of Sch- neider et al. (66) , who showed that H-Ras facilitates transient changes of cell volume required for faster NIH3T3 fibroblast migration, and with data from Nobes and Hall (52) , which showed that mouse embryonic fibroblast migration was lower after Ras blockade with the neutralizing antibody Y13-259. Besides, Akt inhibition strongly prevented cell migration in WT fibroblasts and cut off the scarce migration exhibited by H-ras Ϫ/Ϫ fibroblasts; treatment with the Akt inhibitor, but not with the ERK 1/2 inhibitor, increased wound closure times in WT fibroblasts to values similar to those of H-ras Ϫ/Ϫ fibroblasts. Therefore, PI3K seems to be the main route involved in downstream H-Ras activation in fibroblast movement.
In summary, H-Ras KO fibroblasts synthesize larger amounts of ECM and show reduced motility and reduced proliferative rates with respect to control fibroblasts. The maintenance of those activities under control in resting WT fibroblasts may be the result of a basal H-Ras-dependent downregulation of PI3K/Akt activation. Moreover, the lack of H-Ras appears to be responsible for a higher rise in ECM and a reduced proliferation observed in response to TGF-␤1; the signaling occurs through the ERK 1/2 and Akt routes for both effects. These results suggest that H-Ras isoform activation downregulates ECM synthesis and mediates proliferation and migration by modulating PI3K/Akt activation in resting and stimulated fibroblasts and MEK/ERK activation in stimulated fibroblasts.
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